Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06739278
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
View on ClinicalTrials.gov
Summary
This study intends to further explore the actual efficacy of ustekinumab in the individualized treatment of anal fistula Crohn's disease.
Official title: Analysis for the Efficacy of Individual Treatment of Perianal Fistulizing Crohn's Disease With Ustekinumab
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
119
Start Date
2024-12-20
Completion Date
2025-01-31
Last Updated
2024-12-18
Healthy Volunteers
Not specified
Conditions
Locations (1)
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China